Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.

Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes.
复制标题

DOI:
10.1021/nn4048205
复制
发表时间:
2014-01-28
期刊:
影响因子:
17.1
通讯作者:
Wang, Dong
Wang, Dong
中科院分区:
材料科学1区
文献类型:
--
作者:
Quan, Lingdong;Zhang, Yijia;Crielaard, Bart J.;Dusad, Anand;Lele, Subodh M.;Rijcken, Cristianne J. F.;Metselaar, Josbert M.;Kostkova, Hana;Etrych, Tomas;Ulbrich, Karel;Kiessling, Fabian;Mikuls, Ted R.;Hennink, Wim E.;Storm, Gert;Lammers, Twan;Wang, Dong

文献摘要

参考文献

被引文献

相似文献

纳米医学作为一个新兴的研究方向,越来越多地应用于炎症性疾病的治疗。在这项头对头的比较研究中,四种已建立的地塞米松纳米药物配方,包括脂质体(L-Dex)、核心交联胶束(M-Dex)、缓释聚合物前药(P-Dex-slow)和快速释放聚合物前药(P-Dex-fast),在一种具有等效剂量治疗设计的佐剂诱导的关节炎大鼠模型中进行了评估。研究发现,单次静脉注射后,药物释放动力学较慢的制剂(即M-Dex和P-Dex-slow)的治疗活性持续时间比释放动力学较快的制剂更长,对关节的保护效果更好。这一发现将对未来开发和优化用于类风湿性关节炎临床治疗的纳米药物具有指导意义。这项研究的结果也说明了这种头对头比较研究在转化纳米医学研究中的价值。
As an emerging research direction, nanomedicine has been increasingly utilized to treat inflammatory diseases. In this head-to-head comparison study, four established nanomedicine formulations of dexamethasone, including liposomes (L-Dex), core-crosslinked micelles (M-Dex), slow releasing polymeric prodrugs (P-Dex-slow) and fast releasing polymeric prodrugs (P-Dex-fast), were evaluated in an adjuvant-induced arthritis rat model with an equivalent dose treatment design. It was found that after a single i.v. injection, the formulations with the slower drug release kinetics (i.e. M-Dex and P-Dex-slow) maintained longer duration of therapeutic activity than those with relatively faster drug release kinetics, resulting in better joint protection. This finding will be instructional in the future development and optimization of nanomedicines for the clinical management of rheumatoid arthritis. The outcome of this study also illustrates the value of such head-to-head comparison studies in translational nanomedicine research.
糖皮质激素负载的核心连锁聚合物胶束具有可降低的释放动力学,用于靶向类风湿关节炎的靶向治疗。
DOI: 10.1002/anie.201202713
发表时间: 2012-07-16
影响因子: 16.6
作者:
Crielaard, Bart J.;Rijcken, Cristianne J. F.;Quan, Lingdong;van der Wal, Steffen;Altintas, Isil;van der Pot, Martin;Kruijtzer, John A. W.;Liskamp, Rob M. J.;Schiffelers, Raymond M.;van Nostrum, Cornelus F.;Hennink, Wim E.;Wang, Dong;Lammers, Twan;Storm, Gert
通讯作者: Storm, Gert
DOI: 10.1021/mp100132h
发表时间: 2010-08-02
影响因子: 4.9
作者:
Quan LD;Yuan F;Liu XM;Huang JG;Alnouti Y;Wang D
通讯作者: Wang D
DOI: 10.1038/nrd3958
发表时间: 2013-03
期刊: Nature reviews. Drug discovery
影响因子: --
作者:
通讯作者: --
DOI: 10.1016/j.addr.2009.10.006
发表时间: 2010-02-17
影响因子: 16.1
作者:
Liu, Xin-Ming;Miller, Scott C.;Wang, Dong
通讯作者: Wang, Dong
DOI: 10.1016/j.ijpharm.2013.02.046
发表时间: 2013-09-15
影响因子: 5.8
作者:
Lammers, Twan
通讯作者: Lammers, Twan